Fingerprint
Dive into the research topics of 'Randomized phase II comparison of dose-intense gemcitabine: Thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically